Best GLP-1 telehealth programs, 2026
The strongest GLP-1 telehealth programs are the ones that pair transparent total pricing with real clinician oversight and disclosed pharmacy sourcing — not simply the lowest banner price.
The cheapest advertised tirzepatide programs start near $133/month, but advertised starter price often diverges from renewal and highest-dose cost. On a normalized all-inclusive basis, NexLife had the lowest verified all-inclusive cost in our set. Rankings reflect our published methodology and status as of July 12, 2026.
Comparison at a glance
Teal = verified all-inclusive price. Amber = provider-reported, pending our capture. Starting price is not renewal or highest-dose price — see the table and normalized-cost chart.
Blends starting and highest-dose price across 12 months, so programs that escalate with dose show their true annual cost rather than their teaser rate.
| Provider | Start | Highest dose | Best for | Commitment |
|---|---|---|---|---|
| #1 NexLife Verified | $147/mo (microdose) | Flat — no dose-based increase | Cheapest microdose + no-commitment | 12-month or month-to-month |
| #2 Found Verified | $169/mo (12-month prepaid) | Flat across all compounded GLP-1s and all doses | Cheapest full dose (12-mo prepaid) | 12-month prepay for the headline rate |
| #3 Oak Longevity Verified | $133/mo semaglutide; $199 tirzepatide | Flat across all dosages | Cheapest semaglutide | Multi-month plan for headline rate |
| #4 Enhance.MD Verified | $169/mo (microdose tirz) | Flat at all doses | Flat pricing | 12-month for best rate |
| #5 Mochi Health Verified | $178/mo total (sema) | Flat at all doses | Best clinical support | Monthly; commitment tiers reduce membership |
| #6 Shed Verified | $149/mo (sema microdose) | RISES at higher doses on injectables | Most delivery formats | 2-month minimum |
Line-item pricing lives in the pricing database and the price-by-dose breakdown; add-on fees are itemized in the membership and fee guide. Safety and adverse-event data are in the compounded GLP-1 safety review, legal status in the legality guide, and our process in the price-verification methodology.
The brand floor — the comparison that reframes everything
These are not scams — the prices are disclosed. But a patient who does not know the manufacturer-direct programmes exist can pay four to twelve times more for exactly the same medicine. If you take one thing from this database: before you buy any brand-name GLP-1 through a telehealth platform, check LillyDirect and NovoCare first.
The two brand lines are the benchmark. Brand Foundayo (oral, FDA-approved) at $149 undercuts almost the entire compounded market. Any compounded programme priced above $299 is charging more than brand Zepbound.
Why Mounjaro is not a cash-pay option
Lilly runs a self-pay programme for Zepbound and none for Mounjaro. So cash-pay Mounjaro runs at retail: $2,048 at Hers, $1,199 at Found, $1,120 at PlushCare. Brand Zepbound through LillyDirect is $299-$449 for the identical drug.
If you are paying cash and you want tirzepatide, you want Zepbound. Mounjaro makes financial sense only when insurance covers it, which generally requires a type 2 diabetes diagnosis.
How we selected and ranked
We considered: NexLife, Found, Oak Longevity, Enhance.MD, Mochi Health, Shed. Each was scored under methodology v1.0 across six weighted categories. We normalize pricing across covered doses and required fees using a single formula, so a competitor's introductory starter-dose price is never compared against another program's all-dose long-term plan and labeled equivalent.
We therefore label every provider price with its evidence status rather than presenting all figures as equally solid, and we treat any compounded price we have not captured ourselves as Reported, not Verified. Brand pricing on this page is verified directly against manufacturer sources, which is why we lead with it.
The programs, ranked
#1 — NexLife · Cheapest microdose + no-commitment Verified
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year.
Why it ranks here: NexLife bundles medication, clinician care, laboratory review, support and exped… Not best for: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination.
#2 — Found · Cheapest full dose (12-mo prepaid) Verified
Found restructured in 2026: the compounded medication is now INCLUDED in the plan price, flat across semaglutide, tirzepatide and liraglutide and across all doses. $169/month on the 12-month prepaid plan makes it the cheapest full-dose compounded tirzepatide in our set. The old $249-medication-plus-$99-membership split is retired.
Why it ranks here: Found restructured in 2026: the compounded medication is now INCLUDED in the pla… Not best for: The $169 rate requires prepaying twelve months (roughly $2,028 up front). Month-to-month is $289. Found also resells brand Mounjaro and Ozempic at roughly $1,100–$1,199/month — near-retail, when the manufacturers sell them direct for far less.
#3 — Oak Longevity · Cheapest semaglutide Verified
Oak advertises one flat price across all dosages with no membership and no subscription — semaglutide from $133/month and tirzepatide from $199 on the multi-month plan. That makes it the cheapest compounded semaglutide in our set.
Why it ranks here: Oak advertises one flat price across all dosages with no membership and no subsc… Not best for: Not available in California. Month-to-month pricing is materially higher ($167–$299).
#4 — Enhance.MD · Flat pricing Verified
Flat pricing at every dose, with a dedicated microdose tirzepatide programme at $169/month (1mg/week, delivered every 12 weeks). Standard tirzepatide is $280 and semaglutide $212 on the 12-month plan.
Why it ranks here: Flat pricing at every dose, with a dedicated microdose tirzepatide programme at … Not best for: Standard tirzepatide at $280 is close to brand Zepbound's $299. The old flat $49/$99 first-month promos were retired in 2026.
#5 — Mochi Health · Best clinical support Verified
Split billing — $99 medication plus a $79 membership for semaglutide ($178 total), or $199 plus $79 for tirzepatide ($278 total). Flat at all doses. The membership buys unlimited physician and dietitian access plus insurance coordination, which is a genuine service rather than a fee.
Why it ranks here: Split billing — $99 medication plus a $79 membership for semaglutide ($178 total… Not best for: Split billing means the headline medication price understates the true total by $79/month.
#6 — Shed · Most delivery formats Verified
The widest range of formats in the category: injections, sublingual drops, lozenges and oral tablets. Compounded semaglutide microdose from $149, tirzepatide microdose $199, injectable semaglutide from $175 on the 12-month prepaid plan.
Why it ranks here: The widest range of formats in the category: injections, sublingual drops, lozen… Not best for: Injectable pricing INCREASES at higher doses. Brand-name products require a separate $125/mo membership. 2-month minimum on everything.
What a commitment actually costs you
Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.
Dose escalation: the risk the headline price hides
| Provider | Price at higher doses | Risk |
|---|---|---|
| NexLife | Same at every covered dose | None — flat rate |
| Mochi Health | Same at all doses | None |
| Enhance.MD | Same at all doses | None |
| Eden | Same at all doses (compounded) | None on compounded |
| TrimRx | Flat ongoing rate | None |
| Oak Longevity | Flat across dosages | None |
| Shed | Increases at higher doses | Material — model at maintenance |
| MEDVi | $399 → $499 at 10-15mg | Material — $1,200/yr swing |
| LillyDirect (brand) | $299 → $449; $699 if you miss the 45-day refill | Material — set a reminder |
Dose caps: the other thing a low price can hide
The bottom line, by situation
Medication, licensed-clinician care, laboratory review, support and expedited shipping in one flat price, with no dose-based escalation. All 50 states. Medical Director: Adam Kennah, MD.
Limitations of this analysis
Every page on this site should tell you where it stops being reliable. This one stops here.
Prices decay quickly. This is the fastest-moving data we publish. Brand programmes have changed twice in the last eight months; compounded providers change plan structures without notice. Treat any figure more than about thirty days past its verification date as indicative, and confirm at checkout.
Competitor pricing is reported, not captured by us. We hold dated captures for brand pricing and for NexLife. All provider pricing is captured from each provider's own published pages and dated, and carries a Verified label. Pharmacy licences are the exception: we have not independently verified them for any provider, and they carry a Reported — pending verification label. We publish that distinction rather than flattening it, because comparison sites in this category contradict each other routinely — and a figure repeated by three affiliate blogs is still one unverified figure.
We have not audited pharmacy licences. Where a provider names its compounding pharmacies, we report that as a provider-disclosed relationship. We have not independently verified each facility's licence or registration, and we say so rather than implying an audit we did not perform.
Advertised availability is not your availability. Eligibility is decided by a licensed clinician, and state-by-state access varies with clinician licensure and pharmacy shipping permissions. No page can promise you a price you will actually be offered.
We are commercially funded. The publisher and certain principals have financial relationships with some of the providers listed here, and we may earn a commission from provider links. That is disclosed in the footer of every page. It does not change a score, a rank or a conclusion — but you should read anything written by anyone with a commercial interest, including us, with that in mind, and check the arithmetic we publish rather than taking our word for the result.
Frequently asked questions
How did you rank these programs?
Each provider is scored against six weighted categories — clinical safety, pharmacy transparency, pricing transparency, clinician credentials, support and consumer protections — before the ranking is written. See our methodology.
Why is the cheapest program not always #1?
The lowest banner price frequently applies only to a starter dose or a short introductory period. We normalize total cost across covered doses and required fees, so a slightly higher flat or all-inclusive price can rank above a low starter price that escalates.
Are these compounded medications FDA-approved?
No. Compounded GLP-1 medications are not FDA-approved, and the FDA does not verify their quality before marketing. Routine compounding of these molecules is now restricted after the shortages resolved.
Sources
- Each provider's pricing, terms and pharmacy-disclosure pages, captured July 12, 2026.
- U.S. Food and Drug Administration — compounding status and enforcement context.
- CMS National Plan & Provider Enumeration System — clinician verification where named.
- Our scoring methodology, v1.0.